NCM
VMD icon

Nantahala Capital Management’s Viemed Healthcare VMD Stock Holding History

Nantahala Capital Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.21M Sell
632,445
-251,338
-28% -$2.49M 0.24% 95
2026
Q1 		$8.14M Sell
883,783
-48,662
-5% -$405K 0.3% 79
2025
Q4 		$6.93M Hold
932,445
– – 0.23% 90
2025
Q3 		$6.33M Hold
932,445
– – 0.22% 96
2025
Q2 		$6.44M Hold
932,445
– – 0.25% 77
2025
Q1 		$6.79M Sell
932,445
-2,677
-0.3% -$21K 0.27% 58
2024
Q4 		$7.5M Sell
935,122
-200,000
-18% -$1.74M 0.32% 57
2024
Q3 		$8.32M Sell
1,135,122
-300,000
-21% -$2.14M 0.42% 49
2024
Q2 		$9.4M Sell
1,435,122
-115,000
-7% -$867K 0.55% 36
2024
Q1 		$14.6M Sell
1,550,122
-402,246
-21% -$3.45M 0.84% 26
2023
Q4 		$15.3M Sell
1,952,368
-79,802
-4% -$579K 0.92% 20
2023
Q3 		$13.7M Buy
2,032,170
+303,675
+18% +$2.49M 1.17% 17
2023
Q2 		$16.9M Buy
1,728,495
+135,701
+9% +$1.38M 1.63% 11
2023
Q1 		$15.4M Sell
1,592,794
-177,206
-10% -$1.54M 1.18% 23
2022
Q4 		$13.4M Sell
1,770,000
-20,505
-1% -$139K 0.87% 29
2022
Q3 		$10.7M Buy
1,790,505
+75,579
+4% +$485K 0.7% 39
2022
Q2 		$9.23M Buy
1,714,926
+421,114
+33% +$2.27M 0.46% 46
2022
Q1 		$6.44M Sell
1,293,812
-129,726
-9% -$602K 0.29% 59
2021
Q4 		$7.43M Sell
1,423,538
-9,663
-0.7% -$53.9K 0.26% 67
2021
Q3 		$7.95M Sell
1,433,201
-267,395
-16% -$1.74M 0.25% 73
2021
Q2 		$12.2M Sell
1,700,596
-229,994
-12% -$1.99M 0.35% 60
2021
Q1 		$19.5M Sell
1,930,590
-20,890
-1% -$197K 0.57% 42
2020
Q4 		$15.2M Buy
1,951,480
+453,380
+30% +$3.99M 0.47% 50
2020
Q3 		$13M Hold
1,498,100
– – 0.4% 58
2020
Q2 		$14.4M Hold
1,498,100
– – 0.43% 50
2020
Q1 		$7.13M Hold
1,498,100
– – 0.27% 60
2019
Q4 		$9.38M Hold
1,498,100
– – 0.29% 51
2019
Q3 		$10.3M Buy
+1,498,100
New +$9.98M 0.38% 51

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Nantahala Capital Management's VMD Position: Q2 2026 in Review

Nantahala Capital Management reduced its Viemed Healthcare (VMD) stake by 28% in Q2 2026, selling an estimated $2.49M and leaving 632,445 shares worth $7.21M. The position accounts for 0.24% of the portfolio, ranked #95.

Nantahala Capital Management first reported a position in VMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $19.5M in Q1 2021. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Nantahala Capital Management held 632,445 shares of Viemed Healthcare worth $7.21M as of Q2 2026.
  • Nantahala Capital Management sold 251,338 Viemed Healthcare shares in Q2 2026, an estimated $2.49M.
  • Viemed Healthcare made up 0.24% of Nantahala Capital Management's portfolio in Q2 2026, its #95 holding.
  • Nantahala Capital Management first reported a position in Viemed Healthcare in Q3 2019 and has held it in 28 quarters since.
  • Nantahala Capital Management's Viemed Healthcare position peaked at $19.5M in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.